Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
152 hedge funds and large institutions have $1.53B invested in Silk Road Medical, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 55 reducing their positions, and 27 closing their positions.
237% more call options, than puts
Call options by funds: $4.64M | Put options by funds: $1.38M
7% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 55
4% less funds holding
Funds holding: 159 → 152 (-7)
24% less capital invested
Capital invested by funds: $2B → $1.53B (-$470M)
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$26.4M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$22.5M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$8.54M |
| 4 |
Jennison Associates
New York
|
+$5.7M |
| 5 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$4.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$51.5M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$10.8M |
| 3 |
Amundi
Paris,
France
|
-$7.92M |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$7.65M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$6.89M |
SILK Hedge Fund Activity: Q4 2021 in Review
152 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q4 2021, worth a combined $1.53B — down 24% from $2B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of SILK and 20 opened new positions — a net loss of 7 holders — while 55 trimmed existing stakes and 51 added.
The largest buyer was Deerfield Management, adding an estimated $26.4M. The largest seller was BAMCO Inc, cutting an estimated $51.5M.
- 152 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q4 2021, down from 159 in Q3 2021.
- Funds reported $1.53B of Silk Road Medical, Inc. Common Stock stock for Q4 2021, down 24% quarter-over-quarter.
- 20 funds opened new Silk Road Medical, Inc. Common Stock positions in Q4 2021 and 27 closed out, a net change of -7 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q4 2021 was Deerfield Management, an estimated $26.4M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q4 2021 was BAMCO Inc, an estimated $51.5M sold.
Based on aggregated 13F filings for Q4 2021.